Mike Todisco

Mike Todisco has a strong background in finance and accounting, with over 27 years of experience in various leadership roles. Currently, they serve as the Vice President of Accounting at Obsidian Therapeutics since October 2023. Prior to this, Mike was the Vice President of Accounting and Finance at Kymera Therapeutics from June 2020 to September 2023. Mike has also held executive positions such as Vice President of Corporate Controller at Pear Therapeutics from February 2018 to June 2020, Vice President of Finance at Karyopharm Therapeutics Inc. from September 2016 to January 2018, and Vice President of Finance at Dicerna Pharmaceuticals, Inc. from February 2014 to September 2016. Before that, they worked as the Vice President and Corporate Controller at BG Medicine from June 2013 to February 2014 and as the Vice President and Controller at DUSA Pharmaceuticals, Inc. from May 2005 to April 2013. Mike's early career includes positions as Director of Finance at Art Technology Group from 2003 to 2005, Director of Treasury Services at American Tower from 2001 to 2003, and Director of Finance at Sapient from 1997 to 2001.

Mike Todisco attended Colgate University but their degree and field of study there are unknown. Mike later pursued a Master of Science in Accounting from Northeastern University.